JNJ

185.83

-0.68%↓

ABT

124.99

-1.16%↓

TMO

568.97

+1.87%↑

ISRG

539.52

-0.56%↓

DHR

218.13

-0.03%↓

JNJ

185.83

-0.68%↓

ABT

124.99

-1.16%↓

TMO

568.97

+1.87%↑

ISRG

539.52

-0.56%↓

DHR

218.13

-0.03%↓

JNJ

185.83

-0.68%↓

ABT

124.99

-1.16%↓

TMO

568.97

+1.87%↑

ISRG

539.52

-0.56%↓

DHR

218.13

-0.03%↓

JNJ

185.83

-0.68%↓

ABT

124.99

-1.16%↓

TMO

568.97

+1.87%↑

ISRG

539.52

-0.56%↓

DHR

218.13

-0.03%↓

JNJ

185.83

-0.68%↓

ABT

124.99

-1.16%↓

TMO

568.97

+1.87%↑

ISRG

539.52

-0.56%↓

DHR

218.13

-0.03%↓

Search

Novavax Inc

Avatud

SektorTervishoid

8.46 -1.05

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

8.4

Max

8.57

Põhinäitajad

By Trading Economics

Sissetulek

-412M

107M

Müük

-427M

239M

P/E

Sektori keskmine

3.647

37.461

Kasumimarginaal

44.519

Töötajad

952

EBITDA

-395M

121M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+34.98% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

12. nov 2025

Turustatistika

By TradingEconomics

Turukapital

334M

1.4B

Eelmine avamishind

9.51

Eelmine sulgemishind

8.46

Uudiste sentiment

By Acuity

44%

56%

140 / 373 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Novavax Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. apr 2025, 17:06 UTC

Suurimad hinnamuutused turgudel

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31. märts 2025, 14:19 UTC

Suurimad hinnamuutused turgudel

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4. veebr 2025, 18:52 UTC

Suurimad hinnamuutused turgudel

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11. nov 2024, 14:05 UTC

Suurimad hinnamuutused turgudel

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

19. mai 2025, 14:30 UTC

Peamised uudised

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

19. mai 2025, 13:27 UTC

Peamised uudised

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

8. mai 2025, 17:55 UTC

Tulu

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

8. mai 2025, 15:12 UTC

Tulu

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

28. apr 2025, 17:04 UTC

Tulu

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

30. dets 2024, 23:02 UTC

Omandamised, ülevõtmised, äriostud

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4. dets 2024, 07:09 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Agreement to Close by Dec 30 >NVAX

4. dets 2024, 07:08 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4. dets 2024, 07:07 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4. dets 2024, 07:06 UTC

Omandamised, ülevõtmised, äriostud

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4. dets 2024, 07:06 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4. dets 2024, 07:04 UTC

Omandamised, ülevõtmised, äriostud

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15. nov 2024, 13:34 UTC

Peamised uudised

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15. nov 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

Võrdlus sarnastega

Hinnamuutus

Novavax Inc Prognoos

Hinnasiht

By TipRanks

34.98% tõus

12 kuu keskmine prognoos

Keskmine 11.5 USD  34.98%

Kõrge 19 USD

Madal 6 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Novavax Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

6 ratings

3

Osta

1

Hoia

2

Müü

Tehniline skoor

By Trading Central

5.692 / 6.039Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

140 / 373 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
help-icon Live chat